title: Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
abstract: The development of glioma is a complex process which may be influenced by many factors including the epidermal growth factor (EGF) gene polymorphism. Previous studies showed that EGF rs4444903 polymorphism could result in increased risk of tumorigenesis in multiple human cancers, but published data regarding the association between EGF rs4444903 polymorphism and glioma risk were inconsistent. To derive a more precise estimation of the association between EGF rs4444903 polymorphism and glioma risk, we performed a systematic review and meta-analysis of previous published studies. PubMed, Embase, and the Wanfang databases were systematically searched to identify relevant studies. Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were calculated to assess the strength of the association. Ten published studies with 1,891 glioma cases and 2,836 controls were finally included into the study. Overall, there was a significant association between EGF rs4444903 polymorphism and glioma risk in all four genetic models (the allele model: OR=1.25, 95 % CI 1.15-1.37, P<0.001; the codominant model: OR=1.65, 95 % CI 1.36-1.99, P<0.001; the dominant model: OR=1.27, 95 % CI 1.12-1.44, P<0.001; the recessive model: OR=1.48, 95 % CI 1.25-1.75, P<0.001). Subgroup analyses by ethnicity showed that EGF rs4444903 polymorphism resulted in a higher risk of glioma among both Asians and Caucasians. In conclusion, the results suggest that there is a significant association between EGF rs4444903 polymorphism and glioma risk, and genotypes of EGF rs4444903 mutation contribute to increased host susceptibility to glioma.
authors: Department of Neurosurgery, Xi'an No.1 Hospital, Xi'an, 710002, China.
authors: Mingjun
authors: M
authors: Hu
authors: Hangyu
authors: H
authors: Shi
authors: Zanfeng
authors: Z
authors: Xu
authors: Weiping
authors: W
authors: Liu
mesh_terms: D016022:Case-Control Studies; D004815:Epidermal Growth Factor / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005910:Glioma / Q000209:etiology*; D006801:Humans; D011110:Polymorphism, Genetic / Q000235:genetics*; D012307:Risk Factors
chemical_list: D004815:Epidermal Growth Factor
references: Anticancer Res. 2009 Nov;29(11):4879-85
references: 20032451
references: Clin Cancer Res. 2011 Aug 1;17(15):5161-9
references: 21673069
references: Genet Mol Res. 2012 Aug 29;11(3):2939-45
references: 22782629
references: Int J Biol Markers. 2009 Oct-Dec;24(4):277-81
references: 20108217
references: Curr Opin Oncol. 2011 Nov;23(6):643-7
references: 21825990
references: Cancer Genet Cytogenet. 2007 Jan 1;172(1):33-7
references: 17175377
references: Eur J Gastroenterol Hepatol. 2012 Apr;24(4):458-63
references: 22293333
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: Tumour Biol. 2012 Oct;33(5):1341-8
references: 22457050
references: Genet Test Mol Biomarkers. 2012 May;16(5):449-52
references: 22106858
references: Int J Biol Markers. 2009 Apr-Jun;24(2):77-82
references: 19634110
references: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references: 13655060
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: Cancer Res. 2004 Feb 15;64(4):1220-3
references: 14973082
references: BMC Cancer. 2010 May 21;10:221
references: 20487573
references: Cell. 2012 Mar 30;149(1):36-47
references: 22464322
references: J Int Med Res. 2010 Sep-Oct;38(5):1645-52
references: 21309478
references: J Cancer Res Clin Oncol. 2012 Aug;138(8):1347-54
references: 22481252
references: Clin Cancer Res. 2007 May 1;13(9):2621-6
references: 17473192
references: PLoS One. 2012;7(5):e37531
references: 22662167
references: Nat Rev Clin Oncol. 2012 May 29;9(7):400-13
references: 22641364
references: Tumour Biol. 2012 Apr;33(2):373-81
references: 22274924
references: Acta Oncol. 2010 Aug;49(6):767-75
references: 20446891
references: Pharmacol Ther. 2009 Apr;122(1):1-8
references: 19135477
references: Brain Pathol. 2011 Jan;21(1):74-87
references: 21129061
references: PLoS One. 2012;7(3):e32159
references: 22403631
references: Adv Exp Med Biol. 2012;746:2-11
references: 22639155